Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionToronto Dominion Bank
Latest Disclosed Ownership213,373 shares
Latest Disclosed Value $ 17,086,892
Toronto Dominion Bank reports 37.66% decrease in ownership of EW / Edwards Lifesciences Corporation

On May 15, 2026 - Toronto Dominion Bank filed a 13F-HR form disclosing ownership of 213,373 shares of Edwards Lifesciences Corporation (MX:EW) valued at $17,086,892 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 342,282 shares of Edwards Lifesciences Corporation. This represents a change in shares of -37.66% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 213,373 -128,909 -37.66 17,087 -41.44 0.0088
2026-02-17 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 342,282 126,337 58.50 29,180 73.75 0.0431
2025-11-14 2025-09-30 13F Edwards Lifesciences COM 28176E108 215,945 -60,273 -21.82 16,794 -22.26 0.0260
2025-08-14 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 276,218 12,811 4.86 21,603 13.16 0.0358
2025-05-15 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 263,407 -53,919 -16.99 19,092 -18.73 0.0374
2025-02-19 2024-12-31 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 317,326 17,046 5.68 23,492 18.55 0.0371
2025-02-14 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 317,326 17,046 23,492 0.0114
2024-11-18 2024-09-30 13F/A-1 Edwards Lifesciences COM 28176E108 300,280 4,008 1.35 19,815 -27.59 0.0350
2024-11-14 2024-09-30 13F Edwards Lifesciences COM 28176E108 300,280 4,008 19,815 0.0014
2024-08-14 2024-06-30 13F Edwards Lifesciences COM 28176E108 296,272 -60,504 -16.96 27,367 -19.73 0.0439
2024-05-14 2024-03-31 13F Edwards Lifesciences COM 28176E108 356,776 6,968 1.99 34,094 27.82 0.0534
2024-02-13 2023-12-31 13F Edwards Lifesciences COM 28176E108 349,808 28,261 8.79 26,673 19.73 0.0387
2024-02-14 2023-09-30 13F/A-1 Edwards Lifesciences COM 28176E108 321,547 -10,941 -3.29 22,277 71,758.06 0.0368
2023-11-14 2023-09-30 13F Edwards Lifesciences COM 28176E108 321,547 -10,941 22,277 0.0014
2024-02-14 2023-06-30 13F/A-1 Edwards Lifesciences COM 28176E108 332,488 839 0.25 31 14.81 0.0465
2023-08-10 2023-06-30 13F Edwards Lifesciences COM 28176E108 332,488 839 31 0.0466
2023-05-11 2023-03-31 13F Edwards Lifesciences COM 28176E108 331,649 -74 -0.02 27 12.50 0.0447
2023-02-07 2022-12-31 13F Edwards Lifesciences COM 28176E108 331,723 55,809 20.23 25 -99.89 0.0370
2022-11-09 2022-09-30 13F Edwards Lifesciences COM 28176E108 275,914 -44,003 -13.75 22,791 -25.06 0.0406
2022-08-11 2022-06-30 13F Edwards Lifesciences COM 28176E108 319,917 -50,680 -13.68 30,414 -30.28 0.0567
2022-05-09 2022-03-31 13F Edwards Lifesciences COM 28176E108 370,597 -197,301 -34.74 43,625 -40.70 0.0658
2022-02-04 2021-12-31 13F Edwards Lifesciences COM 28176E108 567,898 278,505 96.24 73,571 124.56 0.0984
2021-11-08 2021-09-30 13F Edwards Lifesciences COM 28176E108 289,393 16,448 6.03 32,762 15.89 0.0513
2021-08-13 2021-06-30 13F/A-1 Edwards Lifesciences COM 28176E108 272,945 -35,392 -11.48 28,269 9.62 0.0438
2021-08-10 2021-06-30 13F Edwards Lifesciences COM 28176E108 272,945 -35,392 28,269 0.0093
2021-05-11 2021-03-31 13F Edwards Lifesciences COM 28176E108 308,337 -83,586 -21.33 25,789 -27.87 0.0454
2021-02-08 2020-12-31 13F Edwards Lifesciences COM 28176E108 391,923 41,706 11.91 35,755 27.91 0.0656
2020-10-30 2020-09-30 13F Edwards Lifesciences COM 28176E108 350,217 -57,826 -14.17 27,954 -0.87 0.0687
2020-08-28 2020-06-30 13F/A-1 Edwards Lifesciences COM 28176E108 408,043 250,554 159.09 28,200 -5.07 0.0715
2020-08-10 2020-06-30 13F Edwards Lifesciences COM 28176E108 408 -157,081 28,200 16,374.6104
2020-05-13 2020-03-31 13F Edwards Lifesciences COM 28176E108 157,489 -86,726 -35.51 29,705 -47.85 0.0907
2020-02-13 2019-12-31 13F Edwards Lifesciences COM 28176E108 244,215 90,997 59.39 56,965 69.08 0.0956
2019-11-12 2019-09-30 13F Edwards Lifesciences COM 28176E108 153,218 -53,022 -25.71 33,691 -11.56 0.0709
2019-08-26 2019-06-30 13F/A-1 Edwards Lifesciences COM 28176E108 206,240 61,627 42.62 38,093 37.71 0.0811
2019-08-13 2019-06-30 13F Edwards Lifesciences COM 28176E108 206,240 61,627 38,093
2019-05-06 2019-03-31 13F Edwards Lifesciences COM 28176E108 144,613 19,735 15.80 27,662 44.65 0.0432
2019-02-07 2018-12-31 13F Edwards Lifesciences COM 28176E108 124,878 -11,367 -8.34 19,124 -19.36 0.0328
2018-11-07 2018-09-30 13F Edwards Lifesciences COM 28176E108 136,245 821 0.61 23,715 20.33 0.0433
2018-08-06 2018-06-30 13F Edwards Lifesciences COM 28176E108 135,424 22,101 19.50 19,709 24.68 0.0400
2018-05-10 2018-03-31 13F Edwards Lifesciences COM 28176E108 113,323 22,184 24.34 15,808 53.89 0.0352
2018-02-08 2017-12-31 13F Edwards Lifesciences COM 28176E108 91,139 11,099 13.87 10,272 17.43 0.0304
2017-11-06 2017-09-30 13F Edwards Lifesciences COM 28176E108 80,040 8,934 12.56 8,747 4.06 0.0281
2017-08-18 2017-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 71,106 13,747 23.97 8,406 55.81 0.0269
2017-05-05 2017-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 57,359 20,496 55.60 5,395 56.20 0.0144
2017-02-06 2016-12-31 13F Edwards Lifesciences COM 28176E108 36,863 30,655 493.80 3,454 361.76 0.0102
2016-11-03 2016-09-30 13F Edwards Lifesciences COM 28176E108 6,208 5,028 426.10 748 533.90 0.0025
2016-08-15 2016-06-30 13F Edwards Lifesciences COM 28176E108 1,180 -467 -28.35 118 -18.62 0.0005
2016-05-04 2016-03-31 13F Edwards Lifesciences COM 28176E108 1,647 -4,965 -75.09 145 -72.22 0.0009
2016-02-09 2015-12-31 13F Edwards Lifesciences COM 28176E108 6,612 3,188 93.11 522 7.19 0.0032
2015-11-10 2015-09-30 13F Edwards Lifesciences COM 28176E108 3,424 456 15.36 487 15.13 0.0028
2015-08-11 2015-06-30 13F Edwards Lifesciences COM 28176E108 2,968 2 0.07 423 0.00 0.0020
2015-05-15 2015-03-31 13F Edwards Lifesciences COM 28176E108 2,966 -1,448 -32.80 423 -24.73 0.0018
2015-02-10 2014-12-31 13F Edwards Lifesciences COM 28176E108 4,414 2,412 120.48 562 174.15 0.0022
2014-11-07 2014-09-30 13F Edwards Lifesciences COM 28176E108 2,002 12 0.60 205 19.88 0.0007
2014-08-11 2014-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 1,990 278 16.24 171 34.65 0.0006
2014-05-09 2014-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 1,712 -34 -1.95 127 10.43 0.0004
2014-02-11 2013-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 1,746 1,746 115 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.